EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSLACG00000013547
Gene Symbol: KIF11
4 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSLACG00000008257
Gene Symbol: KIF5B
4 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSLACG00000016674
Gene Symbol: LTA4H
2 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSLACG00000010036
Gene Symbol: LTB4R
4 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSLACG00000010681
Gene Symbol: LTB4R2
4 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSLACG00000007376
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSLACG00000012041
Gene Symbol: LOXL2
4 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSLACG00000010999
Gene Symbol: MIF
4 Cross references
233 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSLACG00000013031
Gene Symbol: MMP13
4 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSLACG00000016983
Gene Symbol: MMP14
4 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSLACG00000013118
Gene Symbol: MMP2
4 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSLACG00000012930
Gene Symbol: MMP9
4 Cross references
215 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).